Release Date: 01/09/11 13:56 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 37.49KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%